Antimitoscins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer… Grant US-11865130-B2 United States of America 09 Jan 2024
MACROLIDE SENOLYTIC COMPOUNDS Application WO-2023233301-A1 World Intellectual Property Organisation (WIPO) 07 Dec 2023
Anti-mitochondrial inhibitors for oncogenic Ras and Myc Grant US-11561227-B2 United States of America 24 Jan 2023
Azithromycin derivatives containing a phosphonium ion as anticancer agents Grant US-11560395-B2 United States of America 24 Jan 2023
Mitoriboscins: mitochondrial-based therapeutics targeting cancer cells, bacteria and… Grant US-11547679-B2 United States of America 10 Jan 2023
Repurposcins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem… Grant US-11497759-B2 United States of America 15 Nov 2022
TRIPLE COMBINATION THERAPIES FOR TARGETING MITOCHONDRIA AND KILLING CANCER STEM CELLS Application EP-3897658-A4 European Patent Office 19 Oct 2022
Azithromycin derivatives containing a phosphonium ion as anticancer agents Grant US-11427606-B2 United States of America 30 Aug 2022
METHOD OF IDENTIFYING AND TREATING MITOCHONDRIAL SUBTYPE TUMORS Application WO-2022140626-A1 World Intellectual Property Organisation (WIPO) 30 Jun 2022
Mitoriboscins: mitochondrial-based therapeutics targeting cancer cells, bacteria and… Grant US-11364210-B2 United States of America 21 Jun 2022
Mitoriboscins: mitochondrial-based therapeutics targeting cancer cells, bacteria, and… Grant US-11311501-B2 United States of America 26 Apr 2022
Compounds, compositions, methods for treating diseases, and methods for preparing… Grant US-11312690-B2 United States of America 26 Apr 2022
Phosphonium-ion tethered tetracycline drugs for treatment of cancer Grant US-11161862-B2 United States of America 02 Nov 2021
Antimitoscins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer… Grant US-11160821-B2 United States of America 02 Nov 2021
Triphenylphosphonium-tethered tetracyclines for use in treating cancer Grant US-11098073-B2 United States of America 24 Aug 2021
Chemicals and methods to prevent and treat TGF-beta mediated activation of fibroblasts to… Grant US-11096952-B2 United States of America 24 Aug 2021
ANTI-MITOCHONDRIAL INHIBITORS FOR ONCOGENIC RAS AND MYC Application EP-3695005-A4 European Patent Office 26 May 2021
VITAMIN C AND DOXYCYCLINE: A SYNTHETIC LETHAL COMBINATION THERAPY FOR ERADICATING CANCER… Application EP-3612187-A4 European Patent Office 17 Mar 2021
TARGETING HYPOXIC CANCER STEM CELLS (CSCS) WITH DOXYCYCLINE: IMPLICATIONS FOR IMPROVING… Application EP-3612177-A4 European Patent Office 13 Jan 2021
Mitoriboscins: mitochondrial-based therapeutics targeting cancer cells, bacteria, and… Grant US-10512618-B2 United States of America 24 Dec 2019
CHEMICALLY DEFINED MEDIUM FOR THE CULTURE OF CANCER STEM CELL (CSC) CONTAINING CELL… Application WO-2017140876-A1 World Intellectual Property Organisation (WIPO) 24 Aug 2017
CHEMICALLY DEFINED MEDIUM FOR THE CULTURE OF CANCER STEM CELL (CSC) CONTAINING CELL… Application EP-3208331-A1 European Patent Office 23 Aug 2017